OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic ...
Investors eyeing a purchase of OPKO Health Inc (Symbol: OPK) stock, but cautious about paying the going market price of $1.23/share, might benefit from considering selling puts among the alternative ...
Opko Health (NASDAQ: OPK) stock is down more than 30% so far in 2017. Its share price dropped 7% last year. But if you think the poor performance has caused the company's largest investor to lose ...
OPKO Health has improved its financial position by selling most of BioReference, reducing cash burn, and strengthening its balance sheet. Ngenla's profit share with Pfizer has underperformed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback